Research Bridge Partners

Research Bridge Partners is a non-profit organization based in Austin, Texas, dedicated to enhancing the societal and economic impact of research universities in the mid-continent region of the United States. Founded by Isaac Barchas and Reid Hoffman, the organization connects university innovators with commercialization resources across the country. It manages a seed fund that exclusively accepts program-related investments from other charitable entities to support its tax-exempt charitable, educational, and scientific objectives. By focusing on strategic startup creation, Research Bridge Partners aims to advance scientific research in the public interest, ensuring that innovations from mid-continent universities contribute to broader societal benefits.

Linda Grais

Director

Lydia McClure

CEO

3 past transactions

The UT Southwestern Medical Center provides patient care, research facilities, and academic medical centers. They offer cutting-edge therapies, treatments, and first-rate specialized care.

Asalyxa Bio

Seed Round in 2021
Asalyxa Bio is a drug development and platform technology company focused on novel therapeutics to treat major unmet medical needs caused by the dysregulation of immune signaling. With applications across a wide array of disease areas and conditions, Asalyxa Bio's platform technology enables delivery of existing and novel drugs directly into over-reactive immune cells.

Novosteo

Seed Round in 2019
Novosteo Inc. is a company founded in 2017 and located in West Lafayette, Indiana, that focuses on developing and manufacturing innovative drugs aimed at healing bone fractures. The company utilizes a specialized drug discovery platform designed to target the specific needs of fracture healing. By concentrating the healing properties of its drugs at the site of the fracture, Novosteo aims to accelerate the recovery process and enhance the overall healing experience for patients. This approach seeks to mitigate the morbidity, mortality, and productivity loss associated with bone fractures, ultimately improving patient outcomes and reducing the debilitating effects that can arise from such injuries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.